Above products are not available in patent covered areas, or only used for laboratory research and development.
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Crisaborole is a novel, non-steroidal topical anti-inflammatory agent utilized in dermatology. Its core synthesis involves proprietary catalytic processes yielding the active ingredient with molecular formula <strong>C<sub>15</sub>H<sub>18</sub>BNO<sub>4</sub></strong> and CAS No. <strong>906279-23-6</strong>.</p>
<h3>Application</h3>
<ul>
<li>Dermatological manufacturing for mild-to-moderate atopic dermatitis treatment.</li>
<li>Pharmaceutical formulation development for 2% ointment preparations.</li>
<li>Research applications in PDE4 inhibitor mechanism studies.</li>
</ul>
<h3>Precautions</h3>
<p>Strictly for external use only; avoid contact with eyes. Store in cool, dry conditions below 25°C to maintain chemical stability and prevent degradation during long-term inventory management.</p>